Azmi Yerlikaya

Turkey Kutahya Health Sciences University

ORCID
2013年发表
The significance of Ubiquitin proteasome pathway in cancer development
作者: Azmi Yerlikaya, Mustafa Yontem
发表期刊: Recent Patents on Anti-Cancer Drug Discovery
ORCID
2012年发表
Expression of heme oxygenase-1 in response to proteasomal inhibition.
作者: Azmi Yerlikaya
发表期刊: Protein and peptide letters
ORCID
2012年发表
The p53-independent induction of apoptosis in breast cancer cells in response to proteasome inhibitor bortezomib
作者: Azmi Yerlikaya, Emrah Okur, Engin Ulukaya
发表期刊: Tumor Biology
ORCID
2010年发表
Combined effects of the proteasome inhibitor bortezomib and Hsp70 inhibitors on the B16F10 melanoma cell line
作者: -
发表期刊: Molecular Medicine Reports
ORCID
2010年发表
Investigation of the eIF2α phosphorylation mechanism in response to proteasome inhibition in melanoma and breast cancer cells
作者: Azmi Yerlikaya, Harun Dokudur
发表期刊: Molecular Biology
ORCID
2008年发表
Differential sensitivity of breast cancer and melanoma cells to proteasome inhibitor Velcade
作者: -
发表期刊: International Journal of Molecular Medicine
ORCID
2008年发表
Phosphorylation of eIF2α in response to 26S proteasome inhibition is mediated by the haem-regulated inhibitor (HRI) kinase
作者: Azmi Yerlikaya, Scot R. Kimball, Bruce A. Stanley
发表期刊: Biochemical Journal
ORCID
2006年发表
Structural basis for the inactivation of AdoMetDC K12R mutant
作者: -
发表期刊: Protein and Peptide Letters
ORCID
2006年发表
Variations in fatty acids composition of pikeperch (Sander lucioperca) liver with respect to gonad maturation
作者: -
发表期刊: Ecology of Freshwater Fish
ORCID
2005年发表
Effects of highly consumed dietary oils on several hepatic transaminases and lipid oxidation in chick
作者: -
发表期刊: Ecology of Food and Nutrition